As you know, I'm a seasonal pattern trader to my core. I've spent my 30-plus-year career discovering some of the most profitable patterns in the market. But it's not just the seasonals that I'm watching.One of my favorite ways to make safe, passive income is through dividend stocks. And today, I'm going to share three of my favorite dividend-paying companies in 2026—and how you can potentially double your money or more on each (for a fraction of the cost). Here are the three dividend stocks to buy now.Why Y ...

Key Takeaways T. Rowe Price unveils OFLEX, a multi-strategy credit interval fund for wealth clients.The fund invests across private and public credit, including CLOs, direct lending and special situations.OFLEX offers quarterly liquidity and an all-weather strategy targeting stable income and downside risk.T. Rowe Price Group, Inc. (TROW) and Oak Hill Advisors (“OHA”) have announced the launch of the T. Rowe Price OHA Flexible Credit Income Fund (OFLEX). The move marks another step in their efforts to expan ...

Core Insights - Longeviti Neuro Solutions has appointed Robert W. Sharps, CEO of T. Rowe Price Group, to its Board of Directors, indicating a strategic move to enhance governance and growth [1][4][6] Company Overview - Longeviti Neuro Solutions is a neurotechnology company focused on developing advanced implantable and AI-enabled solutions for neurological health, including the ClearFit AI™, the first Acoustic Brain Interface (ABI)™ [1][7] - The company aims to improve the understanding and treatment of neurological conditions while supporting long-term brain health and human performance [4][7] Leadership and Expertise - Robert W. Sharps brings over 30 years of leadership experience in global asset management and corporate governance, overseeing more than $1.5 trillion in assets at T. Rowe Price [2][5] - His appointment is expected to strengthen Longeviti's strategic planning, governance, and partnerships as the company scales its operations [4][6] Product and Technology Development - Longeviti is known for its FDA-cleared products and has full in-house manufacturing capabilities, with over 50 patents worldwide and products approved for use in over 120 hospitals globally [8] - The company has successfully used its neurosurgical implants in more than 4,000 patients, showcasing its impact in the field of neurotechnology [8]

T. Rowe Price Adds Dogecoin And Shiba Inu To New Crypto ETF Investment management firm T. Rowe Price (NASDAQ: $TROW) is adding meme coins Shiba Inu (CRYPTO: $SHIB) and Dogecoin (CRYPTO: $DOGE) to its newest cryptocurrency exchange-traded fund (ETF). T. Rowe Price says DOGE and SHIB will be held alongside Bitcoin (CRYPTO: $BTC) and Ethereum (CRYPTO: $ETH) in its new “Price Active Crypto ETF.” The new ETF is designed to give investors actively managed exposure to cryptocurrencies and digital assets, says th ...

Company Performance - T. Rowe Price (TROW) closed at $87.38, reflecting a -1.37% change from the previous day, underperforming the S&P 500's gain of 1.01% [1] - Over the past month, TROW shares have decreased by 5.51%, while the Finance sector and S&P 500 have lost 6.24% and 2.86%, respectively [1] Upcoming Earnings - The company is expected to report an EPS of $2.44, indicating a 9.42% increase from the same quarter last year [2] - Revenue is projected to be $1.88 billion, representing a 6.49% rise compared to the equivalent quarter last year [2] Full Year Projections - For the full year, earnings are estimated at $10.04 per share and revenue at $7.63 billion, reflecting increases of +3.29% and +4.37% from the prior year [3] Analyst Estimates - Recent changes in analyst estimates indicate a positive outlook for T. Rowe Price's business operations and profit generation capabilities [4] - The consensus EPS projection has decreased by 0.49% in the last 30 days, and T. Rowe Price currently holds a Zacks Rank of 4 (Sell) [6] Valuation Metrics - T. Rowe Price has a Forward P/E ratio of 8.82, which is lower than the industry average Forward P/E of 9.56 [7] - The company has a PEG ratio of 3.71, compared to the average PEG ratio of 0.79 for the Financial - Investment Management industry [8] Industry Context - The Financial - Investment Management industry is currently ranked 188 out of over 250 industries, placing it in the bottom 24% [9]

Core Insights - T. Rowe Price Group, Inc. (NASDAQ:TROW) is recognized as one of the 15 Best Dividend Leaders to buy currently [1] - The company reported assets under management (AUM) of $1.80 trillion at the end of February, a slight increase from $1.79 trillion at the end of January, with net outflows of $5.3 billion for February [2] - The firm launched the T. Rowe Price Emerging Markets Equity Research ETF (TEMR), expanding its ETF offerings into the emerging markets category [3][4] Asset Management Details - As of February 28, equity strategies accounted for $868 billion in AUM, while fixed income strategies, including money market strategies, held $216 billion [2] - Multi-asset strategies totaled $660 billion, and alternatives represented $59 billion in assets [2] ETF Launch Information - The TEMR ETF is designed to hold between 180 and 280 securities, aiming for long-term capital growth through a portfolio of emerging markets equities [4] - The ETF employs a structured portfolio construction approach and utilizes the proprietary fundamental research platform similar to other T. Rowe Price ETFs [4]

Core Viewpoint - T. Rowe Price Group Inc has launched the T. Rowe Price Group Inc Emerging Markets Equity Research ETF, expanding its ETF offerings to provide investors with access to emerging markets equities through a research-driven strategy [1][2][4]. Group 1: ETF Launch and Strategy - The newly launched ETF, named TEMR, aims to deliver long-term capital growth by investing in a diversified portfolio of emerging markets equities, typically holding between 180 and 280 stocks [2][4]. - The ETF employs a research-driven strategy that focuses on active stock selection based on analysts' "best ideas" across various sectors and regions, with a structured portfolio construction process to balance risk and capture growth opportunities [3][4]. - The fund has a net expense ratio of 0.40%, making it a competitive option for investors seeking exposure to emerging markets [3]. Group 2: Expansion of ETF Offerings - With the introduction of TEMR, T. Rowe Price now offers a total of 32 active ETFs, which includes 22 equity funds and 10 fixed-income strategies, reflecting the firm's commitment to expanding its active ETF footprint [4]. - The launch is part of T. Rowe Price's strategy to provide financial advisors with differentiated investment vehicles that help diversify portfolios while capturing long-term growth opportunities in developing economies [5]. Group 3: Company Overview - As of February 28, T. Rowe Price manages $1.8 trillion in client assets, with approximately two-thirds of these assets tied to retirement-related investments, highlighting the firm's focus on long-term portfolio growth [5].

Core Viewpoint - T. Rowe Price Group, Inc. is experiencing significant challenges due to client fund outflows and weaker earnings performance, impacting investor sentiment and future revenue growth [6]. Company Overview - T. Rowe Price Group, Inc. is a global investment management firm based in Baltimore, Maryland, with a market capitalization of approximately $19.5 billion [1]. - The company offers a variety of investment services, including mutual funds, retirement plans, advisory services, and portfolio management for both individual and institutional investors [1][2]. - It is recognized for its active investment management focus and long-term growth strategies, emphasizing diversification and rigorous fundamental research [2]. Stock Performance - The stock is currently down 24.4% from its 52-week high of $118.22 reached in September 2025 [3]. - Year-to-date, TROW has declined by 12.8%, underperforming the Dow Jones Industrials Average, which has seen a 1.3% decline [4]. - Over the past 52 weeks, TROW's stock has decreased by 7.2%, while the Dow Jones has returned 14.4% [4]. - The stock is trading below both the 50-day and 200-day moving averages, indicating a bearish trend [4]. Financial Performance - In February 2026, T. Rowe Price reported net outflows of approximately $5.3 billion, indicating that more investors are withdrawing funds than adding new investments [6]. - The company reported adjusted earnings per share (EPS) of $2.44 for Q4 2025, which missed analyst estimates but represented a 15.1% increase from $2.12 in Q4 2024 [7]. - Competitor BlackRock, Inc. has outperformed TROW, showing a 4.5% increase over the past 52 weeks and an 11.1% year-to-date decline [7].

Group 1 - T. Rowe Price Group, Inc. (NASDAQ:TROW) is recognized as one of the 13 Undervalued Dividend Aristocrats to consider for investment [1] - The company provides investment management services to a diverse clientele, including individuals, institutional investors, and retirement plans [2] - As of FY 2025, T. Rowe Price reported $1.78 trillion in assets under management (AUM), reflecting a 10% growth from FY 2024 [4] - The AUM reached $1.8 trillion at the end of February, indicating continued growth [4] - The company increased its quarterly dividend by 2.4% to $1.30 per share, marking the 40th consecutive year of dividend growth, with an annual dividend yield of 5.82% [4] Group 2 - Evercore ISI lowered its price target for T. Rowe Price from $106 to $99 while maintaining an 'In Line' rating, indicating an upside potential of almost 11% from the current share price [3][7]

Core Insights - Cost pressures are increasingly impacting the outlook for T. Rowe Price Group (TROW), with rising expenses beginning to affect profitability despite the company's strong brand and diversified assets under management (AUM) [1] Financial Performance - Over the past five years ending in 2025, TROW recorded a net revenue CAGR of 5.6%, driven by higher investment advisory fees and expanded investment capabilities [2] - Operating costs have risen at a CAGR of 13.9% during the same period, primarily due to increased spending on technology, employee compensation, and distribution efforts [2] Cost Drivers - Technology spending has become a significant cost driver as TROW upgrades its digital platforms and analytics tools to meet industry demands, which is increasing the company's expense base [3] - Rising compensation costs are also a concern as the firm competes for skilled professionals in portfolio management, analysis, and technology [3] Strategic Initiatives - TROW continues to focus on long-term growth through acquisitions, partnerships, and product development, including the acquisition of Oak Hill Advisors in February 2025, which enhances its position in alternative investments [4] - The company is also enhancing its investment offerings and distribution reach while improving retirement-focused solutions through advanced planning tools and fintech capabilities [4] Industry Context - The asset management industry is experiencing structural changes as investors shift towards passive investment vehicles like ETFs and index funds, making TROW's ongoing investments in technology and new products crucial for attracting additional assets [5] - TROW's peers, Franklin Resources and First Horizon, are facing similar expense challenges, with Franklin Resources experiencing a CAGR of 7.9% in expenses and First Horizon a CAGR of 8.9% [6][7][8] Market Performance - T. Rowe Price's shares have declined by 15.2% in the past six months, which is better than the industry's decline of 19.6% [9] - The company currently holds a Zacks Rank of 3 (Hold) [11]